JP2004255053A - Medical fluid injection method and apparatus therefor - Google Patents

Medical fluid injection method and apparatus therefor Download PDF

Info

Publication number
JP2004255053A
JP2004255053A JP2003051559A JP2003051559A JP2004255053A JP 2004255053 A JP2004255053 A JP 2004255053A JP 2003051559 A JP2003051559 A JP 2003051559A JP 2003051559 A JP2003051559 A JP 2003051559A JP 2004255053 A JP2004255053 A JP 2004255053A
Authority
JP
Japan
Prior art keywords
press
fitting
freezing
drug
drug solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003051559A
Other languages
Japanese (ja)
Other versions
JP4218370B2 (en
Inventor
Sadayasu Inagaki
定保 稲垣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daikin Industries Ltd
Original Assignee
Daikin Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikin Industries Ltd filed Critical Daikin Industries Ltd
Priority to JP2003051559A priority Critical patent/JP4218370B2/en
Publication of JP2004255053A publication Critical patent/JP2004255053A/en
Application granted granted Critical
Publication of JP4218370B2 publication Critical patent/JP4218370B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To enable infusional administration of a medical fluid directly into an intended position of a specified injection object such as an affected area of the human body without using an injection needle or the like. <P>SOLUTION: The medical fluid of a therapeutic agent or the like is dissolved into a physiological saline solution and is frozen and solidified by freezing. The medical fluid in the solidified state can be rapidly injected into the predetermined position of the predetermined injection object such as the affected area of the human body. <P>COPYRIGHT: (C)2004,JPO&NCIPI

Description

【0001】
【発明の属する技術分野】
本願発明は、治療薬等の薬液を患部等所定の注入対象に注入する薬液注入方法および装置に関するものである。
【0002】
【従来の技術】
従来、例えば病気等の治療に際して治療薬を患部に投与するには、経口投与による方法や注射器による方法が、一般に採用されている(例えば特許文献1参照)。
【0003】
【特許文献1】
WO 98/48871号公報(第1−16頁、図1、図2)
【0004】
【発明が解決しようとする課題】
しかし、経口投与法による問題点は、副作用が強いことである。特に胃などの消化器官を経由するため、安全性を高める必要があり、そのため治療に不要な成分も含まれることになる。
【0005】
一方、注射による投与方法では、苦痛をともなうため、頻繁な投与には適さない。また、注射後、薬液成分が血流により全身に行き渡るため、治療の必要な患部へ投与される量が少なくなり、治療効率が低い。
【0006】
また、これら従来の方法の場合、薬の種類によっては、上記の副作用を抑えるための別の薬を同時に摂取する必要がある。
【0007】
本願発明は、これらの問題を解決するためになされたもので、治療薬等の薬液(液体や固体)を生理食塩水に溶解させた上で、凍結固体化させ、患部等圧入対象の所定の部位に高速で圧入することにより、患部等の所定の部位に対して有効に薬を投与できるようにした薬液注入方法および装置を提供することを目的とするものである。
【0008】
【課題を解決するための手段】
本願発明は、同目的を達成するために、次のような課題解決手段を備えて構成されている。
【0009】
(1) 第1の課題解決手段
この発明の第1の課題解決手段は、治療薬等の薬液を生理食塩水に溶解させた後、冷凍することによって凍結固体化し、該固体化された状態において患部等圧入対象の所定の部位に高速で圧入するようにしたことを特徴としている。
【0010】
一般に治療薬等の薬液の大部分は水溶性であるため、水を含ませることにより冷凍して凍結させることができる。
【0011】
したがって、以上のような薬液注入方法によれば、注射針を使用しないで、治療の必要な患部等所定の圧入対象の必要な個所に直接治療薬等の薬液を注入することができる。
【0012】
(2) 第2の課題解決手段
この発明の第2の課題解決手段は、上記第1の課題解決手段の構成において、圧入直前に固体化された薬液の表面を加熱融解させるようにしたことを特徴としている。
【0013】
このようにして上記凍結固体化された薬液を圧入するようにすると、例えば人の治療に用いた時に、圧入時における皮膚や筋肉との摩擦を極力低減することができ、殆ど痛みを無くすることが可能になる。
【0014】
(3) 第3の課題解決手段
この発明の第3の課題解決手段は、上記第1又は第2の課題解決手段の構成において、圧入時の圧入速度を調節することにより、患部等圧入対象の所望の深さ位置に圧入できるようにしたことを特徴としている。
【0015】
このような構成によれば、人体の患部等、体内の任意の位置にある患部に対し、例えばCT、MRI等の患部位置特定手段を併用して確実に投与することができる。
【0016】
(4) 第4の課題解決手段
この発明の第4の課題解決手段は、生理食塩水に溶解させた治療薬等の薬液を凍結固体化する冷凍凍結手段と、該冷凍凍結手段により凍結固体化された薬液を患部等圧入対象の所定の部位に高速で圧入する薬液圧入手段からなることを特徴としている。
【0017】
一般に治療薬の大部分は水溶性であるため、水を含ませることにより冷凍して凍結させることができる。
【0018】
したがって、以上のような薬液注入方法によれば、注射針を使用しないで、治療の必要な患部等必要な個所に直接治療薬等の薬液を注入することができる。
【0019】
(5) 第5の課題解決手段
この発明の第5の課題解決手段は、第4の課題解決手段の構成において、圧入直前に固体化された薬液の表面を加熱融解させる加熱手段を設けたことを特徴としている。
【0020】
このようにして上記凍結固体化された薬液を圧入するようにすると、例えば人の治療に用いた時に、圧入時における皮膚や筋肉との摩擦を極力低減することができ、殆ど痛みを無くすることが可能になる。
【0021】
(6) 第6の課題解決手段
この発明の第6の課題解決手段は、上記第4又は第5の課題解決手段の構成において、圧入時の圧入速度を調節する圧入速度調節手段を設けることにより、患部等圧入対象の所望の深さ位置に圧入できるようにしたことを特徴としている。
【0022】
このような構成によれば、人体の患部等、体内の任意の位置にある患部に対し、例えばCT、MRI等の患部位置特定手段を併用して確実に投与することができる。
【0023】
【発明の効果】
以上のような薬液注入方法および装置によれば、次のようなメリットを得ることができる。
【0024】
▲1▼ 経口投与では副作用の強い薬等も、患部へ直接投与することができるようになる。従って、安全になるとともに、別途副作用を抑制するための薬を必要としなくなる。
【0025】
▲2▼ 微小な患部への投与も可能になる(微小サイズの利点)。
【0026】
▲3▼ 筋肉等の動きのある部分への投与が可能となる(高速性の利点)。
【0027】
▲4▼ 安定性の低い薬の投与が可能となる(高速性の利点)。
【0028】
▲5▼ 樹木や皮膚の硬い動物など表面が硬いものへの投与も可能となる(無針、微小サイズ、底摩擦の利点)。
【0029】
【発明の実施の形態】
(実施の形態1)
図1〜図5は、本願発明の実施の形態1に係る薬液注入方法および同薬液注入方法を実施する薬液注入装置の構成を合わせて示している。
【0030】
図1は、それらの全体の構成を示しており、符号1は治療薬等の薬液貯留層であり、該薬液貯留層1内には、薬液Cが生理食塩水に溶解された状態で貯留されている。
【0031】
この薬液(治療薬その他)Cは、必要に応じ定量ポンプ3により汲み出されて、薬液供給ライン2を介して薬液圧入手段5の多数の薬液凍結ユニット51a〜51d内に供給されるようになっている。薬液圧入手段5の各薬液凍結ユニット51a,51b,51c,51dは、例えば図2に示すような形状と寸法オーダーの薬液の凍結体(薬液凍結体)52a,52b,52c,52dを形成するのに対応した形状と大きさのスリーブ構造体よりなり、その外周囲には各々薬液凍結用の冷却素子53,53,53,53と、該薬液凍結用の冷却素子53,53,53,53により凍結された薬液凍結体52a,52b,52c,52dの表面を圧入直前に加熱融解させる加熱素子54,54,54,54とが設けられている。
【0032】
一方、符号10は高圧ポンプ等の高圧空気発生手段であり、該高圧空気発生手段10部分で発生せしめられた高圧空気は、電磁開閉弁12を備えた高圧空気供給ライン11、11a,11b,11c,11dを介して上記薬液凍結ユニット51a,51b,51c,51dの後端側に供給されるようになっている。そして、その供給/停止は、例えばマイコン等の制御ユニットを介して制御される上記電磁開閉弁12の開閉によってなされる。
【0033】
(薬液注入方法)
次に、上記のように構成された薬液注入装置を用いて実施される薬液注入方法について説明する。
【0034】
すなわち、先ず上記薬液貯留層1から生理食塩水に溶解させた薬液Cを定量ポンプ6により上記各薬液凍結ユニット51a,51b,51c,51d内に所定量ごとに供給する。次に、それらを上記冷却素子53,53,53,53により図2のような大きさと形状の薬液凍結体52a,52b,52c,52dに凍結させ、保持させて置く。
【0035】
次に、この状態で、必要に応じて上記高圧空気発生手段10を作動させ、上述の電磁開閉弁12を開く。また、それよりも若干早いタイミングで、上記加熱素子54,54,54,54を作動させて、図4のように、薬液凍結体52a,52b,52c,52dの表面を融解させる。すると、上記各薬液凍結ユニット51a,51b,51c,51dの後部に瞬間的に高圧空気が供給されて、薬液凍結ユニット51a,51b,51c,51d内の薬液凍結体52a,52b,52c,52dが、同薬液凍結ユニット51a,51b,51c,51dの先端55,55,55,55から高速で飛び出し、例えば対応する人体6の体内6bの所定の患部7に皮膚6aを貫通して圧入される。
【0036】
この圧入に際し、上記圧入速度は、例えば上記供給される高圧空気の圧力値を可変することにより、任意に調節設定できるようになっており、これによって人体6内の所望の深さの患部位置に適切に薬液凍結体52a,52b,52c,52dが到達し、かつ留まるように圧入投与される。
【0037】
このようにして患部7に投与された薬液凍結体52a,52b,52c,52dは、例えば図5に示されるように、体温により速やかに融解し、極めて効果的に患部に作用する。
【0038】
なお、上記図1の構成では、上記薬液保持部5の4組の薬液凍結ユニット51a〜51dしか設けていないが、これらは、実際には例えば図3に示すように、5mm×5mmの寸法の薬液保持部5に対し、図2のような薬液量2μgの薬液凍結体52a,52b・・・が2500個保持される位のユニット数がセットされる(トータル薬液量5mg)。
【0039】
もちろん、これらの数、量は任意のものであることは言うまでもない。
【0040】
以上のように、この発明の実施の形態1に係る薬液注入方法は、治療薬等の薬液を生理食塩水に溶解させた後、冷凍することによって凍結固体化し、該固体化された状態において患部等圧入対象の所定の部位に高速で圧入するようにしたことを特徴としている。
【0041】
一般に治療薬等の薬液の大部分は水溶性であるため、水を含ませることにより冷凍して凍結させることができる。
【0042】
したがって、以上のような薬液注入方法によれば、注射針を使用しないで、治療の必要な患部等所定の圧入対象の必要な個所に直接治療薬等の薬液を注入することができる。
【0043】
また同方法では、上記の構成において、圧入直前に固体化された薬液の表面を加熱融解させるようにしたことを特徴としている。
【0044】
このようにして上記凍結固体化された薬液を圧入するようにすると、例えば人の治療に用いた時に、皮膚や筋肉との摩擦を極力低減することができ、殆ど痛みを無くすることが可能になる。
【0045】
さらに同方法では、上記の構成において、圧入時の圧入速度を調節することにより、患部等圧入対象の所望の深さ位置に圧入できるようにしたことを特徴としている。
【0046】
このような構成によれば、人体の患部等、体内の任意の位置にある患部に対し、例えばCT、MRI等の患部位置特定手段を併用して確実に投与することができる。
【0047】
また、この発明の実施の形態1に係る薬液注入装置は、上記のように生理食塩水に溶解させた治療薬等の薬液を凍結固体化する冷凍凍結手段と、該冷凍凍結手段により凍結固体化された薬液を患部等圧入対象の所定の部位に高速で圧入する薬液圧入手段からなることを特徴としている。
【0048】
一般に治療薬の大部分は水溶性であるため、水を含ませることにより冷凍して凍結させることができる。
【0049】
したがって、以上のような薬液注入方法によれば、注射針を使用しないで、治療の必要な患部等必要な個所に直接治療薬等の薬液を注入することができる。
【0050】
また、同装置では、上記の構成において、圧入直前に固体化された薬液の表面を加熱融解させる加熱手段を設けたことを特徴としている。
【0051】
このようにして上記凍結固体化された薬液を圧入するようにすると、例えば人の治療に用いた時に、圧入時における皮膚や筋肉との摩擦を極力低減することができ、殆ど痛みを無くすることが可能になる。
【0052】
さらに同装置では、上記の構成において、圧入時の圧入速度を調節する圧入速度調節手段を設けることにより、患部等圧入対象の所望の深さ位置に圧入できるようにしたことを特徴としている。
【0053】
このような構成によれば、人体の患部等、体内の任意の位置にある患部に対し、例えばCT、MRI等の患部位置特定手段を併用して確実に投与することができる。
【0054】
したがって、以上のような薬液注入方法および装置によれば、次のようなメリットを得ることができる。
【0055】
▲1▼ 経口投与では副作用の強い薬等も、患部へ直接投与することができるようになる。従って、安全になるとともに、別途副作用を抑制するための薬を必要しなくなる。
【0056】
▲2▼ 微小な患部への投与も可能になる(微小サイズの利点)。
【0057】
▲3▼ 筋肉等の動きのある部分への投与が可能となる(高速性の利点)。
【0058】
▲4▼ 安定性の低い薬の投与が可能となる(高速性の利点)。
【0059】
▲5▼ 樹木や皮膚の硬い動物など表面が硬いものへの投与も可能となる(無針、微小サイズ、底摩擦の利点)。
【0060】
(実施の形態2)
次に図6は、本願発明の実施の形態2に係る薬液注入方法および薬液注入装置の構成を示している。
【0061】
この実施の形態のものは、安定性の高い薬液A(貯留槽1A)と、安定性の高い薬液B(貯留槽1B)とを各薬液供給ライン2a,2bを介して合成装置8に供給し、該合成装置8で高活性で安定性が低い治療薬に合成し、その後、1本の薬液供給ライン4により上述のものと同様の薬液圧入手段5を介して、人体6の体内6bの患部7部分に順次圧入投与するようにしたことを特徴とするものである。
【0062】
このような薬液注入方法および装置によると、例えば経口摂取法や血管注入法では、患部に薬液が到達するまでに分解してしまうような高活性で安定性が低い治療薬(A+B)を患部に対して迅速かつ直接に投与できるようになる。
【0063】
(実施の形態3)
さらに、図7は本願発明の実施の形態3に係る薬液注入方法および薬液注入装置の構成を示している。
【0064】
この実施の形態のものは、1ショットの薬液投与量を増やすに際し、上述のように薬液凍結体の本数を増やしたりすることなく、薬液圧入手段5部分の1本の薬液凍結ユニット50部分から、連続して圧入投与するようにしたことを特徴としている。
【図面の簡単な説明】
【図1】本願発明の実施の形態1に係る薬液注入方法および薬液注入装置の構成の全体を示す図である。
【図2】同薬液注入方法および薬液注入装置の構成における薬液凍結体の構成を示す拡大図である。
【図3】同薬液注入方法および薬液注入装置における薬液凍結ユニット増本時の薬液保持部の構成を示す拡大図である。
【図4】同薬液注入方法および薬液注入装置における薬液凍結体の表面融解状態の構造を示す断面図である。
【図5】同薬液注入方法および薬液注入装置における薬液凍結体の体内侵入後の薬液が融解して行く状態を示す拡大説明図である。
【図6】本願発明の実施の形態2に係る薬液注入方法および薬液注入装置の構成を示す図である。
【図7】本願発明の実施の形態3に係る薬液注入方法および薬液注入装置の構成を示す図である
【符号の説明】
1は薬液貯留層、5は薬液圧入手段、3は定量ポンプ、6は人体、7は患部、10は高圧空気発生手段、12は電磁開閉弁、51a〜51dは薬液凍結ユニット、52a〜52dは薬液凍結体、53は薬液凍結用冷却素子、54は薬液表面融解用加熱素子である。
[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a method and an apparatus for injecting a drug such as a therapeutic drug into a predetermined injection target such as an affected part.
[0002]
[Prior art]
2. Description of the Related Art Conventionally, in order to administer a therapeutic agent to an affected part, for example, in treating a disease or the like, a method of oral administration or a method of using a syringe has been generally adopted (for example, see Patent Document 1).
[0003]
[Patent Document 1]
WO 98/48871 (pages 1-16, FIGS. 1 and 2)
[0004]
[Problems to be solved by the invention]
However, a problem with the oral administration method is that side effects are strong. In particular, since the drug passes through the digestive organs such as the stomach, it is necessary to enhance safety, and therefore, components that are unnecessary for treatment are included.
[0005]
On the other hand, the administration method by injection involves pain and is not suitable for frequent administration. Further, after the injection, the medicinal solution component is distributed throughout the body by the blood flow, so that the amount to be administered to the affected area requiring treatment is reduced, and the treatment efficiency is low.
[0006]
In addition, in the case of these conventional methods, it is necessary to simultaneously take another drug for suppressing the above-mentioned side effects, depending on the kind of the drug.
[0007]
The present invention has been made in order to solve these problems. A medical solution (liquid or solid) such as a therapeutic agent is dissolved in physiological saline, then frozen and solidified, and a predetermined amount of a target to be pressed into an affected part or the like is injected. It is an object of the present invention to provide a method and an apparatus for injecting a drug solution, in which a medicine can be effectively administered to a predetermined site such as an affected area by press-fitting the site at a high speed.
[0008]
[Means for Solving the Problems]
The present invention has the following problem solving means in order to achieve the above object.
[0009]
(1) First Problem-Solving Means A first problem-solving means of the present invention is to dissolve a drug solution such as a therapeutic agent in physiological saline, and then freeze and solidify the solution by freezing. It is characterized in that it is press-fitted at a high speed into a predetermined part to be press-fitted such as an affected part.
[0010]
In general, most drug solutions such as therapeutic agents are water-soluble, so that they can be frozen and frozen by including water.
[0011]
Therefore, according to the above-described method for injecting a drug, a drug such as a therapeutic drug can be directly injected into a required part of a predetermined press-fit target such as an affected part requiring treatment without using an injection needle.
[0012]
(2) Second Problem-Solving Means A second problem-solving means according to the present invention is that, in the structure of the first problem-solving means, the surface of the solidified chemical solution is heated and melted immediately before press-fitting. Features.
[0013]
When the frozen and solidified drug solution is press-fitted in this way, for example, when used for human treatment, friction with the skin or muscle at the time of press-fitting can be reduced as much as possible, and pain is almost eliminated. Becomes possible.
[0014]
(3) Third Problem-Solving Means The third problem-solving means of the present invention, in the configuration of the first or second problem-solving means, adjusts the press-fitting speed at the time of press-fitting to thereby apply a target such as an affected part. It is characterized in that it can be pressed into a desired depth position.
[0015]
According to such a configuration, it is possible to reliably administer to an affected part at an arbitrary position in the body, such as an affected part of the human body, by using the affected part position specifying means such as CT and MRI together.
[0016]
(4) Fourth Problem Solving Means A fourth problem solving means of the present invention is a freezing / freezing means for freezing and solidifying a drug solution such as a therapeutic drug dissolved in physiological saline, and a freezing / solidifying means by the freezing / freezing means. It is characterized by comprising a liquid medicine press-fitting means for press-fitting a given liquid medicine at a high speed into a predetermined portion to be press-fitted such as an affected part.
[0017]
Generally, most of the therapeutic agents are water-soluble, and can be frozen and frozen by including water.
[0018]
Therefore, according to the above-described method for injecting a drug, a drug such as a therapeutic drug can be directly injected into a necessary part such as an affected part requiring treatment without using an injection needle.
[0019]
(5) Fifth Problem Solving Means A fifth problem solving means of the present invention is the fourth problem solving means, wherein a heating means for heating and melting the surface of the solidified chemical solution immediately before press-fitting is provided. It is characterized by.
[0020]
When the frozen and solidified drug solution is press-fitted in this way, for example, when used for human treatment, friction with the skin or muscle at the time of press-fitting can be reduced as much as possible, and pain is almost eliminated. Becomes possible.
[0021]
(6) Sixth Problem Solving Means A sixth problem solving means of the present invention is the above-described fourth or fifth problem solving means, wherein a press-fit speed adjusting means for adjusting a press-fitting speed at the time of press-fitting is provided. It is characterized in that it can be press-fitted to a desired depth position of a press-fit target such as an affected part.
[0022]
According to such a configuration, it is possible to reliably administer to an affected part at an arbitrary position in the body, such as an affected part of the human body, by using the affected part position specifying means such as CT and MRI together.
[0023]
【The invention's effect】
According to the chemical solution injection method and apparatus as described above, the following advantages can be obtained.
[0024]
{Circle around (1)} In oral administration, drugs with strong side effects can be directly administered to the affected area. Therefore, it becomes safe and does not require a drug for separately suppressing side effects.
[0025]
(2) It is also possible to administer to a very small affected area (the advantage of a very small size).
[0026]
(3) It is possible to administer to moving parts such as muscles (the advantage of high speed).
[0027]
(4) It is possible to administer a drug with low stability (advantage of high speed).
[0028]
{Circle around (5)} It is also possible to administer to hard objects such as trees and animals with hard skin (the advantages of needlelessness, micro size and bottom friction).
[0029]
BEST MODE FOR CARRYING OUT THE INVENTION
(Embodiment 1)
FIGS. 1 to 5 also show the configuration of a drug solution injection method according to Embodiment 1 of the present invention and a drug solution injection device that performs the drug solution injection method.
[0030]
FIG. 1 shows the entire configuration thereof, and reference numeral 1 denotes a drug solution storage layer for a therapeutic drug or the like. In the drug solution storage layer 1, a drug solution C is stored in a state dissolved in physiological saline. ing.
[0031]
The chemical solution (therapeutic drug and the like) C is pumped by the metering pump 3 as needed, and supplied to the chemical solution freezing units 51a to 51d of the chemical solution press-fitting means 5 via the chemical solution supply line 2. ing. Each of the chemical liquid freezing units 51a, 51b, 51c, 51d of the chemical liquid press-in means 5 forms frozen liquids (chemical liquid frozen bodies) 52a, 52b, 52c, 52d of a shape and a dimension order as shown in FIG. And a cooling element 53, 53, 53, 53 for freezing the chemical solution, and a cooling element 53, 53, 53, 53 for freezing the chemical solution. Heating elements 54, 54, 54, 54 are provided for heating and melting the surfaces of the frozen drug solution frozen bodies 52a, 52b, 52c, 52d immediately before press-fitting.
[0032]
On the other hand, reference numeral 10 denotes high-pressure air generating means such as a high-pressure pump. The high-pressure air generated by the high-pressure air generating means 10 is supplied to high-pressure air supply lines 11, 11 a, 11 b, 11 c having an electromagnetic valve 12. , 11d are supplied to the rear end side of the chemical liquid freezing units 51a, 51b, 51c, 51d. The supply / stop is performed by, for example, opening and closing the electromagnetic on-off valve 12 controlled via a control unit such as a microcomputer.
[0033]
(Chemical solution injection method)
Next, a description will be given of a drug solution injection method performed using the drug solution injector configured as described above.
[0034]
That is, first, the drug solution C dissolved in physiological saline is supplied from the drug solution storage layer 1 to the respective drug solution freezing units 51a, 51b, 51c, 51d by the metering pump 6 in predetermined amounts. Next, they are frozen by the cooling elements 53, 53, 53, 53 into frozen chemicals 52a, 52b, 52c, 52d having the size and shape as shown in FIG.
[0035]
Next, in this state, the high-pressure air generating means 10 is operated as needed, and the above-mentioned electromagnetic on-off valve 12 is opened. At a slightly earlier timing, the heating elements 54, 54, 54, 54 are operated to melt the surfaces of the frozen chemicals 52a, 52b, 52c, 52d as shown in FIG. Then, high-pressure air is instantaneously supplied to the rear of each of the chemical liquid freezing units 51a, 51b, 51c, 51d, and the chemical liquid frozen bodies 52a, 52b, 52c, 52d in the chemical liquid freezing units 51a, 51b, 51c, 51d. At the same time, the drug solution freezing units 51a, 51b, 51c, and 51d jump out of the tips 55, 55, 55, and 55 of the same body at high speed, and for example, are pressed into the corresponding affected part 7 of the body 6b of the human body 6 through the skin 6a.
[0036]
At the time of this press-fitting, the press-fitting speed can be arbitrarily adjusted and set, for example, by changing the pressure value of the supplied high-pressure air, whereby the affected portion at a desired depth in the human body 6 can be set. The liquid medicine frozen bodies 52a, 52b, 52c and 52d are appropriately injected and injected so as to reach and stay there.
[0037]
The frozen drug solutions 52a, 52b, 52c, 52d thus administered to the diseased part 7 are quickly melted by body temperature, as shown in FIG. 5, for example, and act on the diseased part very effectively.
[0038]
In the configuration of FIG. 1 described above, only four sets of chemical solution freezing units 51a to 51d of the chemical solution holding unit 5 are provided, but these are actually, for example, as shown in FIG. The number of units that can hold 2500 chemical liquid frozen bodies 52a, 52b,... Having a chemical liquid amount of 2 μg as shown in FIG. 2 is set in the chemical liquid holding section 5 (total chemical liquid amount 5 mg).
[0039]
Of course, these numbers and amounts are arbitrary.
[0040]
As described above, in the method for injecting a drug solution according to Embodiment 1 of the present invention, a drug solution such as a therapeutic agent is dissolved in physiological saline, and then frozen and solidified by freezing. It is characterized in that it is press-fitted at a high speed into a predetermined portion to be press-fitted at a high speed.
[0041]
In general, most drug solutions such as therapeutic agents are water-soluble, so that they can be frozen and frozen by including water.
[0042]
Therefore, according to the above-described method for injecting a drug, a drug such as a therapeutic drug can be directly injected into a required part of a predetermined press-fit target such as an affected part requiring treatment without using an injection needle.
[0043]
Further, the method is characterized in that, in the above configuration, the surface of the solidified chemical solution is heated and melted immediately before press-fitting.
[0044]
When the frozen and solidified drug solution is press-fitted in this way, for example, when used for human treatment, friction with the skin and muscles can be reduced as much as possible, and almost pain can be eliminated. Become.
[0045]
Further, this method is characterized in that, in the above configuration, the press-fitting speed at the time of press-fitting is adjusted so that the press-fitting can be performed at a desired depth position of the press-fitting target such as an affected part.
[0046]
According to such a configuration, it is possible to reliably administer to an affected part at an arbitrary position in the body, such as an affected part of the human body, by using the affected part position specifying means such as CT and MRI together.
[0047]
In addition, the drug solution injection device according to Embodiment 1 of the present invention includes a freezing / freezing means for freezing and solidifying a drug solution such as a therapeutic drug dissolved in physiological saline as described above, and a freezing / solidifying means using the freezing / freezing means. It is characterized by comprising a liquid medicine press-fitting means for press-fitting a given liquid medicine at a high speed into a predetermined portion to be press-fitted such as an affected part.
[0048]
Generally, most of the therapeutic agents are water-soluble, and can be frozen and frozen by including water.
[0049]
Therefore, according to the above-described method for injecting a drug, a drug such as a therapeutic drug can be directly injected into a necessary part such as an affected part requiring treatment without using an injection needle.
[0050]
Further, the apparatus is characterized in that, in the above configuration, heating means for heating and melting the surface of the solidified chemical solution immediately before press-fitting is provided.
[0051]
When the frozen and solidified drug solution is press-fitted in this way, for example, when used for human treatment, friction with the skin or muscle at the time of press-fitting can be reduced as much as possible, and pain is almost eliminated. Becomes possible.
[0052]
Further, the apparatus is characterized in that, in the above configuration, a press-fitting speed adjusting means for adjusting the press-fitting speed at the time of press-fitting is provided so that the press-fitting can be performed at a desired depth position of the press-fitting target such as an affected part.
[0053]
According to such a configuration, it is possible to reliably administer to an affected part at an arbitrary position in the body, such as an affected part of the human body, by using an affected part position specifying means such as CT and MRI.
[0054]
Therefore, according to the above-described method and apparatus for injecting a chemical solution, the following advantages can be obtained.
[0055]
{Circle around (1)} In oral administration, drugs with strong side effects can be directly administered to the affected area. Therefore, while being safe, a drug for separately suppressing side effects is not required.
[0056]
(2) It is also possible to administer to a very small affected area (the advantage of a very small size).
[0057]
(3) It is possible to administer to moving parts such as muscles (the advantage of high speed).
[0058]
(4) It is possible to administer a drug with low stability (advantage of high speed).
[0059]
{Circle around (5)} It is also possible to administer to hard objects such as trees and animals with hard skin (the advantages of needlelessness, micro size and bottom friction).
[0060]
(Embodiment 2)
Next, FIG. 6 shows a configuration of a drug solution injection method and a drug solution injection device according to Embodiment 2 of the present invention.
[0061]
In this embodiment, a highly stable chemical solution A (reservoir 1A) and a highly stable chemical solution B (reservoir 1B) are supplied to the synthesizing device 8 via the respective chemical solution supply lines 2a and 2b. The synthetic device 8 is used to synthesize a therapeutic agent having high activity and low stability, and thereafter the affected part of the human body 6 in the body 6b of the human body 6 via the single chemical solution supply line 4 through the same chemical solution press-fitting means 5 as described above. It is characterized in that seven parts are sequentially injected and administered.
[0062]
According to such a drug solution injection method and device, for example, in an oral ingestion method or a blood vessel injection method, a highly active and low-stability therapeutic drug (A + B) that is decomposed by the time the drug solution reaches the affected area is applied to the affected area. To be administered quickly and directly.
[0063]
(Embodiment 3)
Further, FIG. 7 shows a configuration of a drug solution injection method and a drug solution injection device according to Embodiment 3 of the present invention.
[0064]
In this embodiment, when increasing the dose of the drug solution for one shot, without increasing the number of frozen drug solutions as described above, from one of the drug solution freezing units 50 of the drug solution press-fitting means 5 portion, It is characterized by the fact that it is injected continuously.
[Brief description of the drawings]
FIG. 1 is a diagram showing an entire configuration of a drug solution injection method and a drug solution injection device according to Embodiment 1 of the present invention.
FIG. 2 is an enlarged view showing a configuration of a frozen drug solution in the drug solution injection method and the drug solution injection device.
FIG. 3 is an enlarged view showing a configuration of a drug solution holding unit when adding a drug solution freezing unit in the drug solution injection method and the drug solution injection device.
FIG. 4 is a cross-sectional view showing the structure of the frozen liquid body in the surface-melted state in the liquid medicine injection method and the liquid medicine injection device.
FIG. 5 is an enlarged explanatory view showing a state in which the liquid medicine is melted after the frozen liquid body enters the body in the liquid medicine injection method and the liquid medicine injection device.
FIG. 6 is a diagram illustrating a configuration of a drug solution injection method and a drug solution injection device according to Embodiment 2 of the present invention.
FIG. 7 is a diagram showing a configuration of a chemical solution injection method and a chemical solution injection device according to Embodiment 3 of the present invention.
1 is a chemical storage layer, 5 is a chemical liquid injection means, 3 is a metering pump, 6 is a human body, 7 is an affected part, 10 is a high pressure air generating means, 12 is an electromagnetic on-off valve, 51a to 51d are chemical liquid freezing units, and 52a to 52d are A frozen drug solution, 53 is a cooling element for freezing the drug solution, and 54 is a heating element for melting the surface of the drug solution.

Claims (6)

治療薬等の薬液を生理食塩水に溶解させた後、冷凍することによって凍結固体化し、該固体化された状態において患部等圧入対象の所定の部位に高速で圧入するようにしたことを特徴とする薬液注入方法。After a drug solution such as a therapeutic drug is dissolved in physiological saline, it is frozen and solidified by freezing, and in the solidified state, it is press-fitted at a high speed to a predetermined site of a target such as an affected part. How to inject chemicals. 圧入直前に固体化された薬液の表面を加熱融解させるようにしたことを特徴とする請求項1記載の薬液注入方法。2. The method according to claim 1, wherein the surface of the solidified chemical solution is heated and melted immediately before press-fitting. 圧入時の圧入速度を調節することにより、患部等圧入対象の所望の深さ位置に圧入できるようにしたことを特徴とする請求項1又は2記載の薬液注入方法。3. The method according to claim 1, wherein the press-fitting speed at the time of press-fitting is adjusted so that the press-fitting can be performed at a desired depth position of the press-fitting target such as an affected part. 生理食塩水に溶解させた治療薬等の薬液を凍結固体化する冷凍凍結手段と、該冷凍凍結手段により凍結固体化された薬液を患部等圧入対象の所定の部位に高速で圧入する薬液圧入手段からなることを特徴とする薬液注入装置。Freezing and freezing means for freezing and solidifying a drug solution such as a therapeutic drug dissolved in physiological saline, and a drug solution press-in means for press-fitting the drug solution frozen and solidified by the freezing / freezing means at a high speed into a predetermined site to be pressed into an affected part or the like. A chemical liquid injection device characterized by comprising: 圧入直前に固体化された薬液の表面を加熱融解させる加熱手段を設けたことを特徴とする請求項4記載の薬液注入装置。5. The chemical injection device according to claim 4, further comprising a heating means for heating and melting the surface of the solidified chemical immediately before the press-fitting. 圧入時の圧入速度を調節する圧入速度調節手段を設けることにより、患部等圧入対象の所望の深さ位置に圧入できるようにしたことを特徴とする請求項4又は5記載の薬液注入装置。6. The liquid injector according to claim 4, wherein a press-in speed adjusting means for adjusting a press-in speed at the time of press-in is provided so that the press-in can be performed at a desired depth position of a target to be press-fitted such as an affected part.
JP2003051559A 2003-02-27 2003-02-27 Chemical injection device Expired - Fee Related JP4218370B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003051559A JP4218370B2 (en) 2003-02-27 2003-02-27 Chemical injection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003051559A JP4218370B2 (en) 2003-02-27 2003-02-27 Chemical injection device

Publications (2)

Publication Number Publication Date
JP2004255053A true JP2004255053A (en) 2004-09-16
JP4218370B2 JP4218370B2 (en) 2009-02-04

Family

ID=33116677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003051559A Expired - Fee Related JP4218370B2 (en) 2003-02-27 2003-02-27 Chemical injection device

Country Status (1)

Country Link
JP (1) JP4218370B2 (en)

Also Published As

Publication number Publication date
JP4218370B2 (en) 2009-02-04

Similar Documents

Publication Publication Date Title
DE602004004331T2 (en) Implantable pump for the treatment of obesity
Langer New methods of drug delivery
RU2207845C2 (en) Solid medicinal form with prolonged effect for parenteral administration and method for its preparing
ES2303169T3 (en) NEEDLE FOR INTRADERMAL ADMINISTRATION OF SUBSTANCES THAT HAVE LIMIT MEANS OF PENETRATION.
RU2539556C2 (en) Intermittent drug feed from lachrymal opening plug
JP5449872B2 (en) Pulsatile drug delivery
US10709882B2 (en) Therapeutic agent delivery apparatus and process
CN101035593A (en) Methods and devices for renal nerve blocking
Kilts Potential new drug delivery systems for antidepressants: an overview
Parsons et al. A miniature syringe pump for continuous administration of drugs and hormones: the Mill Hill Infuser
EP3860568A1 (en) Slurry and solution compositions
US10049189B2 (en) Method for developing parenteral therapeutic product with drug delivery device through clinical trial
Langer Controlling the movement of molecules
JP4218370B2 (en) Chemical injection device
KR20160043186A (en) Oriental acupuncture for drug delivery, having seperating needle point formed with biodegraderable high module and its manufacture method.
JP2009268905A (en) Transvenous soaker catheter
Zaffaroni Systems for controlled drug delivery
Amkraut et al. Osmotic delivery of peptides and macromolecules
Stahl et al. Recent advances in drug delivery technology for neurology
US10420923B1 (en) Method and device for intrathecal administering of immunoglobulin
Stahl Applications of new drug delivery technologies to Parkinson’s disease and dopaminergic agents
CN104427988A (en) Liquid medicine having carbon dioxide dissolved therein, and therapeutic method using same
BAVEJA Drug delivery: Steps toward replacing the pill
EP4159206A1 (en) Long-lasting reabsorbable subcutaneous implant with sustained release of pre-concentrated pharmacologically active substance in polymer for the treatment of erectile dysfunction and benign prostatic hyperplasia
Malik A Review on Implantable Drug Delivery System

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051220

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080617

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081021

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081103

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111121

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111121

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees